An effective technology

Long-term pain relief
The beneficial effects can last up to a year

Multi-action treatment
ARTHROMAC lubricates and cushions the joint, provides analgesic, anti-inflammatory, antioxidant and chondroprotective effects, stimulates proteoglycan, collagen and HA synthesis, and facilitates the evacuation of cartilaginous debris

Resistance to degradation
Thanks to a proprietary cross-linking technology, ARTHROMAC provides enhanced viscoelastic properties and a better resistance to enzymatic, oxidative, thermal and mechanical degradations

Optimal molecular weight
Protected from structural damages thanks to a proprietary sterilization process, the HA in ARTHROMAC has an optimal average size in terms of beneficial effects on the extracellular matrix

Highly concentrated
ARTHROMAC 3% provides the highest HA concentration and the highest HA content per injection on the market

Localized treatment
ARTHROMAC directly targets the affected joint with a therapeutic action entirely concentrated into the zone to be treated

Repeatable therapy
The injection of ARTHROMAC can be re-performed when the symptoms return

Extended indication
ARTHROMAC is approved for all synovial joints (particularly the knee and hip, but also the ankle, shoulder, elbow, wrist, fingers, toes, and the temporomandibular and facet joints) and for post-surgical management (particularly in the reduction of post-arthroscopic pain)